Total Payments
$4,975
2024 Payments
$2,803
Companies
46
Transactions
209
Payment Breakdown by Category
Food & Beverage$4,311 (86.6%)
Education$664.38 (13.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,311 | 202 | 86.6% |
| Education | $664.38 | 7 | 13.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $349.08 | 11 | $0 (2024) |
| Incyte Corporation | $332.58 | 11 | $0 (2024) |
| Astellas Pharma US Inc | $317.23 | 8 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $304.71 | 12 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $295.83 | 21 | $0 (2024) |
| SOBI, INC | $271.62 | 6 | $0 (2024) |
| PFIZER INC. | $258.33 | 11 | $0 (2024) |
| Exelixis Inc. | $240.02 | 4 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $216.15 | 8 | $0 (2024) |
| Daiichi Sankyo Inc. | $192.62 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,803 | 123 | Astellas Pharma US Inc ($304.31) |
| 2023 | $2,172 | 86 | Incyte Corporation ($224.97) |
All Payment Transactions
209 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | PFIZER INC. | BOSULIF (Drug), ELREXFIO, ADCETRIS | Food and Beverage | In-kind items and services | $23.95 | General |
| Category: METABOLIC DISEASE;ONCOLOGY | ||||||
| 12/17/2024 | Incyte Corporation | MONJUVI (Drug), PEMAZYRE | Food and Beverage | Cash or cash equivalent | $20.99 | General |
| Category: Oncology | ||||||
| 12/16/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $26.06 | General |
| 12/13/2024 | Takeda Pharmaceuticals U.S.A., Inc. | FRUZAQLA (Drug) | Food and Beverage | In-kind items and services | $32.14 | General |
| Category: ONCOLOGY | ||||||
| 12/10/2024 | Lilly USA, LLC | VERZENIO (Drug), JAYPIRCA | Food and Beverage | In-kind items and services | $20.28 | General |
| Category: Oncology | ||||||
| 12/06/2024 | PharmaEssentia USA Corporation | BESREMI (Drug) | Food and Beverage | In-kind items and services | $21.25 | General |
| Category: Oncology | ||||||
| 11/25/2024 | Pharmacosmos Therapeutics Inc. | MONOFERRIC (Drug) | Food and Beverage | In-kind items and services | $22.89 | General |
| Category: HEMATOLOGY | ||||||
| 11/21/2024 | Janssen Biotech, Inc. | DARZALEX (Biological), TECVAYLI, TALVEY | Food and Beverage | In-kind items and services | $17.75 | General |
| Category: Oncology | ||||||
| 11/20/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $19.51 | General |
| Category: Oncology | ||||||
| 11/19/2024 | Lilly USA, LLC | VERZENIO (Drug), JAYPIRCA | Food and Beverage | In-kind items and services | $21.93 | General |
| Category: Oncology | ||||||
| 11/18/2024 | ABBVIE INC. | VENCLEXTA (Drug) | Food and Beverage | In-kind items and services | $26.69 | General |
| Category: ONCOLOGY | ||||||
| 11/15/2024 | PFIZER INC. | INLYTA (Drug), PADCEV | Food and Beverage | In-kind items and services | $30.89 | General |
| Category: ONCOLOGY | ||||||
| 11/14/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $29.96 | General |
| Category: ONCOLOGY | ||||||
| 11/11/2024 | ABBVIE INC. | EPKINLY (Drug), IMBRUVICA | Food and Beverage | In-kind items and services | $15.94 | General |
| Category: ONCOLOGY | ||||||
| 11/07/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $20.25 | General |
| Category: Oncology | ||||||
| 10/24/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | GILOTRIF (Drug) | Food and Beverage | In-kind items and services | $26.38 | General |
| Category: ONCOLOGY | ||||||
| 10/23/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $4.68 | General |
| Category: Oncology | ||||||
| 10/23/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $0.55 | General |
| Category: Oncology | ||||||
| 10/23/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $0.54 | General |
| Category: Oncology | ||||||
| 10/21/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $18.94 | General |
| Category: Oncology | ||||||
| 10/05/2024 | PFIZER INC. | ELREXFIO (Drug), ADCETRIS | Food and Beverage | In-kind items and services | $14.67 | General |
| Category: ONCOLOGY | ||||||
| 10/03/2024 | ABBVIE INC. | VENCLEXTA (Drug) | Food and Beverage | In-kind items and services | $22.67 | General |
| Category: ONCOLOGY | ||||||
| 09/24/2024 | Exelixis Inc. | CABOMETYX (Drug) | Food and Beverage | In-kind items and services | $21.42 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
| 09/17/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $19.57 | General |
| Category: Oncology | ||||||
| 09/16/2024 | E.R. Squibb & Sons, L.L.C. | OPDUALAG (Drug) | Food and Beverage | Cash or cash equivalent | $19.35 | General |
| Category: Oncology | ||||||
About Jamie Steele, APRN
Jamie Steele, APRN is a Emergency healthcare provider based in Venice, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/29/2018. The National Provider Identifier (NPI) number assigned to this provider is 1366933079.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jamie Steele, APRN has received a total of $4,975 in payments from pharmaceutical and medical device companies, with $2,803 received in 2024. These payments were reported across 209 transactions from 46 companies. The most common payment nature is "Food and Beverage" ($4,311).
Ad
Practice Information
- Specialty Emergency
- Other Specialties Acute Care, Gerontology
- Location Venice, FL
- Active Since 05/29/2018
- Last Updated 04/17/2025
- Taxonomy Code 163WE0003X
- Entity Type Individual
- NPI Number 1366933079
Products in Payments
- JAKAFI (Drug) $277.77
- OPDIVO (Biological) $255.53
- Doptelet (Drug) $202.24
- Enhertu (Drug) $192.62
- Nubeqa (Drug) $165.43
- VERZENIO (Drug) $143.64
- KEYTRUDA (Biological) $143.36
- NINLARO (Drug) $129.16
- INLYTA (Drug) $127.19
- JAYPIRCA (Drug) $123.97
- IMFINZI (Biological) $105.85
- Lenvima (Drug) $89.43
- ZEPZELCA (Drug) $80.62
- Alecensa (Biological) $80.43
- BESREMI (Drug) $74.80
- GILOTRIF (Drug) $74.34
- IBRANCE (Drug) $73.44
- Padcev (Drug) $72.51
- DOPTELET (Drug) $69.38
- ULTOMIRIS (Biological) $68.62
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.